Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X

English version České info

Human adenoviruses from multiple species bind to coagulation factor X (FX), yet the importance of this interaction in adenovirus dissemination is unknown. Upon contact with blood, vectors based on adenovirus serotype 5 (Ad5) binds to FX via the hexon protein with nanomolar affinity, leading to selective uptake of the complex into the liver and spleen. The Ad5:FX complex putatively targets heparan sulfate proteoglycans (HSPGs). The aim of this study was to elucidate the specific requirements for Ad5:FX-mediated cellular uptake in this high-affinity pathway, specifically the HSPG receptor requirements as well as the role of penton base-mediated integrin engagement in subsequent internalisation. Removal of HS sidechains by enzymatic digestion or competition with highly-sulfated heparins/heparan sulfates significantly decreased FX-mediated Ad5 cell binding in vitro and ex vivo. Removal of N-linked and, in particular, O-linked sulfate groups significantly attenuated the inhibitory capabilities of heparin, while the chemical inhibition of endogenous HSPG sulfation dose-dependently reduced FX-mediated Ad5 cellular uptake. Unlike native heparin, modified heparins lacking O- or N-linked sulfate groups were unable to inhibit Ad5 accumulation in the liver 1h after intravascular administration of adenovirus. Similar results were observed in vitro using Ad5 vectors possessing mutations ablating CAR- and/or α_v integrin binding, demonstrating that attachment of the Ad5:FX complex to the cell surface involves HSPG sulfation. Interestingly, Ad5 vectors ablated for α_v integrin binding showed markedly delayed cell entry, highlighting the need for an efficient post-attachment internalisation signal for optimal Ad5 uptake and transport following surface binding mediated through FX. This study therefore integrates the established model of α_v integrin-dependent adenoviral infection with the high-affinity FX-mediated pathway. This has important implications for mechanisms that define organ targeting following contact of human adenoviruses with blood.

Vyšlo v časopise: Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X. PLoS Pathog 6(10): e32767. doi:10.1371/journal.ppat.1001142
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001142

Souhrn

Zdroje

1. RussellWC

2009 Adenoviruses: update on structure and function. J Gen Virol 90 1 20

2. HongJY

LeeHJ

PiedraPA

ChoiEH

ParkKH

2001 Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis. Clin Infect Dis 32 1423 1429

3. EchavarriaM

2008 Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 21 704 715

4. KojaoghlanianT

FlomenbergP

HorwitzMS

2003 The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 13 155 171

5. Blackwell Munsgardt 2004 Adenovirus. Am J Transplant 4 Suppl 10 101 104

6. LionT

BaumgartingerR

WatzingerF

Matthes-MartinS

SudaM

2003 Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102 1114 1120

7. MunozFM

PiedraPA

DemmlerGJ

1998 Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis 27 1194 1200

8. Leruez-VilleM

MinardV

LacailleF

BuzynA

AbachinE

2004 Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis 38 45 52

9. TakayamaR

HatakeyamaN

SuzukiN

YamamotoM

HayashiT

2007 Quantification of adenovirus species B and C viremia by real-time PCR in adults and children undergoing stem cell transplantation. J Med Virol 79 278 284

10. BergelsonJM

CunninghamJA

DroguettG

Kurt-JonesEA

KrithivasA

1997 Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275 1320 1323

11. LawLK

DavidsonBL

2005 What does it take to bind CAR? Mol Ther 12 599 609

12. WickhamTJ

MathiasP

ChereshDA

NemerowGR

1993 Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73 309 319

13. WickhamTJ

FilardoEJ

ChereshDA

NemerowGR

1994 Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol 127 257 264

14. AlemanyR

CurielDT

2001 CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther 8 1347 1353

15. MartinK

BrieA

SaulnierP

PerricaudetM

YehP

2003 Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism. Mol Ther 8 485 494

16. NicolCG

GrahamD

MillerWH

WhiteSJ

SmithTA

2004 Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats. Mol Ther 10 344 354

17. ParkerAL

WaddingtonSN

NicolCG

ShayakhmetovDM

BuckleySM

2006 Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108 2554 2561

18. Di PaoloNC

ShayakhmetovDM

2009 Adenovirus de-targeting from the liver. Curr Opin Mol Ther 11 523 531

19. CoyneCB

BergelsonJM

2005 CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 57 869 882

20. KalyuzhniyO

Di PaoloNC

SilvestryM

HofherrSE

BarryMA

2008 Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A 105 5483 5488

21. WaddingtonSN

McVeyJH

BhellaD

ParkerAL

BarkerK

2008 Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132 397 409

22. MadischI

WolfelR

HarsteG

PommerH

HeimA

2006 Molecular identification of adenovirus sequences: a rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients. J Med Virol 78 1210 1217

23. KampmannB

CubittD

WallsT

NaikP

DepalaM

2005 Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 130 595 603

24. EskoJD

LindahlU

2001 Molecular diversity of heparan sulfate. J Clin Invest 108 169 173

25. BishopJR

SchukszM

EskoJD

2007 Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446 1030 1037

26. EndressT

LampeM

BriggsJA

KrausslichHG

BrauchleC

2008 HIV-1-cellular interactions analyzed by single virus tracing. Eur Biophys J 37 1291 1301

27. JohnsonKM

KinesRC

RobertsJN

LowyDR

SchillerJT

2009 Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 83 2067 2074

28. SummerfordC

SamulskiRJ

1998 Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72 1438 1445

29. ShuklaD

LiuJ

BlaiklockP

ShworakNW

BaiX

1999 A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99 13 22

30. ShayakhmetovDM

GaggarA

NiS

LiZY

LieberA

2005 Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 79 7478 7491

31. LyonM

DeakinJA

GallagherJT

1994 Liver heparan sulfate structure. A novel molecular design. J Biol Chem 269 11208 11215

32. MacArthurJM

BishopJR

StanfordKI

WangL

BensadounA

2007 Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117 153 164

33. VongchanP

WardaM

ToyodaH

ToidaT

MarksRM

2005 Structural characterization of human liver heparan sulfate. Biochim Biophys Acta 1721 1 8

34. KaliaM

ChandraV

RahmanSA

SehgalD

JameelS

2009 Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J Virol 83 12714 12724

35. TiwariV

O'DonnellCD

OhMJ

Valyi-NagyT

ShuklaD

2005 A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread. Biochem Biophys Res Commun 338 930 937

36. KimM

ZinnKR

BarnettBG

SumerelLA

KrasnykhV

2002 The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur J Cancer 38 1917 1926

37. BoyleMP

EnkeRA

ReynoldsJB

MogayzelPJJr

GugginoWB

2006 Membrane-associated heparan sulfate is not required for rAAV-2 infection of human respiratory epithelia. Virol J 3 29

38. O'DonnellJ

TaylorKA

ChapmanMS

2009 Adeno-associated virus-2 and its primary cellular receptor–Cryo-EM structure of a heparin complex. Virology 385 434 443

39. ZautnerAE

KornerU

HenkeA

BadorffC

SchmidtkeM

2003 Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J Virol 77 10071 10077

40. ShayakhmetovDM

EberlyAM

LiZY

LieberA

2005 Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J Virol 79 1053 1061

41. SmithTA

IdamakantiN

RollenceML

Marshall-NeffJ

KimJ

2003 Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum Gene Ther 14 777 787

42. HidakaC

MilanoE

LeopoldPL

BergelsonJM

HackettNR

1999 CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Invest 103 579 587

43. GreberU

PuntenerD

2009 DNA tumour virus entry- from plasma membrane to the nucleus. Semin Cell Dev Biol 20 631 642

44. SafaiyanF

KolsetSO

PrydzK

GottfridssonE

LindahlU

1999 Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem 274 36267 36273

45. EskoJD

WeinkeJL

TaylorWH

EkborgG

RodenL

1987 Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J Biol Chem 262 12189 12195

46. BameKJ

EskoJD

1989 Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase. J Biol Chem 264 8059 8065

47. BaiX

EskoJD

1996 An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation. J Biol Chem 271 17711 17717

48. BasuA

KandaT

BeyeneA

SaitoK

MeyerK

2007 Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells. J Virol 81 3933 3941

49. XuZ

TianJ

SmithJS

ByrnesAP

2008 Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J Virol 82 11705 11713

50. SmithJS

XuZ

TianJ

StevensonSC

ByrnesAP

2008 Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver. Hum Gene Ther 19 547 554

51. ShashkovaEV

DoroninK

SenacJS

BarryMA

2008 Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus. Cancer Res 68 5896 5904

52. Di PaoloNC

van RooijenN

ShayakhmetovDM

2009 Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver. Mol Ther 17 675 684

53. ShiehMT

WuDunnD

MontgomeryRI

EskoJD

SpearPG

1992 Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J Cell Biol 116 1273 1281

54. BarthH

SchaferC

AdahMI

ZhangF

LinhardtRJ

2003 Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 278 41003 41012

55. AsokanA

ConwayJC

PhillipsJL

LiC

HeggeJ

Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nat Biotechnol 28 79 82

56. PeraboL

GoldnauD

WhiteK

EndellJ

BoucasJ

2006 Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism. J Virol 80 7265 7269

57. StanfordKI

WangL

CastagnolaJ

SongD

BishopJR

Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance. J Biol Chem 285 286 294

58. SakaiT

KisielW

1990 Binding of human factors X and Xa to HepG2 and J82 human tumor cell lines. Evidence that factor Xa binds to tumor cells independent of factor Va. J Biol Chem 265 9105 9113

59. KazamaY

KomiyamaY

KisielW

1993 Tissue factor pathway inhibitor and protease nexin-1 are major factor Xa binding proteins on the HepG2 cell surface. Blood 81 676 682

60. CraftJ

EppsK

BrancatoS

SerfisA

2003 Incorporation of blood clotting factor X into phospholipid model membranes: fluorescence microscopy imaging and subphase effects surrounding the lipid phase transition region. Journal of Colloid and Interface Science 268 181 187

61. SabharwalAK

PadmanabhanK

TulinskyA

MathurA

GorkaJ

1997 Interaction of calcium with native and decarboxylated human factor X. Effect of proteolysis in the autolysis loop on catalytic efficiency and factor Va binding. J Biol Chem 272 22037 22045

62. ScanduraJM

AhmadSS

WalshPN

1996 A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin. Biochemistry 35 8890 8902

63. PlesciaJ

AltieriDC

1996 Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J 319 Pt 3 873 879

64. TuveS

WangH

JacobsJD

YumulRC

SmithDF

2008 Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathog 4 e1000189

65. KritzAB

NicolCG

DishartKL

NelsonR

HolbeckS

2007 Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loop. Mol Ther 15 741 749

66. AlbaR

BradshawAC

ParkerAL

BhellaD

WaddingtonSN

2009 Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114 965 971

67. RezaieAR

1998 Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa. J Biol Chem 273 16824 16827

68. RezaieAR

2000 Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding. J Biol Chem 275 3320 3327

69. GhoshT

ChattopadhyayK

MarschallM

KarmakarP

MandalP

2009 Focus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluation. Glycobiology 19 2 15

70. HuskensD

VermeireK

ProfyAT

ScholsD

2009 The candidate sulfonated microbicide, PRO 2000, has potential multiple mechanisms of action against HIV-1. Antiviral Res 84 38 47

71. FletcherPS

WallaceGS

MesquitaPM

ShattockRJ

2006 Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants. Retrovirology 3 46

72. Von SeggernDJ

KehlerJ

EndoRI

NemerowGR

1998 Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein. J Gen Virol 79 Pt 6 1461 1468